Financial Performance - Operating revenue for Q1 2025 reached CNY 243,417,951.59, representing a 38.24% increase from CNY 176,082,931.74 in Q1 2024[9] - Net profit attributable to shareholders was CNY 23,496,404.46, up 44.97% from CNY 16,208,105.24 in the same period last year[9] - The company recorded a 98.03% increase in other income to CNY 2,338,009.84, mainly from government subsidies[12] - The comprehensive income for Q1 2025 totaled ¥23,103,592.77, up from ¥15,803,721.65 in Q1 2024, reflecting an increase of approximately 46.5%[33] - The total profit for Q1 2025 was approximately ¥18.28 million, compared to ¥27.78 million in Q1 2024, reflecting a decline of about 34.0%[36] Assets and Liabilities - Total assets increased by 6.77% to CNY 1,262,486,220.56 as of March 31, 2025, compared to CNY 1,182,407,451.92 at the end of 2024[9] - Total current assets increased to ¥1,011,643,648.18 as of March 31, 2025, up from ¥936,119,359.99 on December 31, 2024, representing an increase of approximately 8.06%[26] - Total liabilities rose to ¥392,245,173.59 as of March 31, 2025, from ¥335,786,790.26 on December 31, 2024, marking an increase of around 16.76%[28] - The company's debt-to-asset ratio increased to 31.07% from 28.40% year-on-year[9] Cash Flow - The net cash flow from operating activities surged by 511.90% to CNY 27,155,539.94, compared to a negative CNY 6,592,805.75 in Q1 2024[9] - The cash flow from operating activities for Q1 2025 was approximately ¥27.16 million, a significant improvement from a negative cash flow of ¥6.59 million in Q1 2024[38] - Net cash flow from operating activities was $27,820,960.68, a decrease of $5,345,006.55 compared to the previous period[41] Shareholder Information - The total number of shares at the end of the period is 155,154,500, with 76.22% being restricted shares and 23.78% being unrestricted shares[17] - The largest shareholder, Chen Jing, holds 44.61% of the shares, totaling 69,221,000 shares[18] - The top ten shareholders collectively hold 75.12% of the total shares, with a slight decrease of 23.90% in the number of shares held[19] - There are 8,125 common shareholders as of the end of the period[17] Expenses - Sales expenses rose by 43.21% to CNY 6,139,575.79, attributed to higher personnel costs and marketing expenses[12] - Research and development expenses for Q1 2025 were ¥8,256,969.80, compared to ¥6,709,803.93 in Q1 2024, indicating an increase of approximately 23.0%[32] - The company incurred sales expenses of approximately ¥4.04 million in Q1 2025, down from ¥6.04 million in Q1 2024, representing a decrease of about 33.2%[36] Compliance and Events - No major events such as lawsuits or external guarantees were reported during the period[22] - The company has complied with all disclosure obligations regarding related party transactions[22] - The financial report has not been audited[25] - The company has fulfilled all previously disclosed commitments in a timely manner[22]
聚星科技(920111) - 2025 Q1 - 季度财报